Cargando…
Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States
Asymptomatic SARS-CoV-2 infection and delayed implementation of diagnostics have led to poorly defined viral prevalence rates. To address this, we analyzed seropositivity in US adults who have not previously been diagnosed with COVID-19. Individuals with characteristics that reflect the US populatio...
Ejemplares similares
-
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
por: Kalish, Heather, et al.
Publicado: (2021) -
Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses
por: Hicks, Jennifer, et al.
Publicado: (2020) -
Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses
por: Hicks, Jennifer, et al.
Publicado: (2021) -
Dynamics of SARS-CoV-2 Seroprevalence in a Large US population Over a Period of 12 Months
por: Karkanitsa, Maria, et al.
Publicado: (2023) -
Standardization of enzyme-linked immunosorbent assays for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling
por: Klumpp-Thomas, Carleen, et al.
Publicado: (2020)